These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9762861)

  • 1. Epidemiology, pathogenesis and therapeutic modalities in hemolytic-uremic syndrome.
    Zimmerhackl LB
    Kidney Blood Press Res; 1998; 21(2-4):290-2. PubMed ID: 9762861
    [No Abstract]   [Full Text] [Related]  

  • 2. [Emerging infectious diseases--E coli O157 infections].
    Nagayama K; Kodama T; Honda T
    Nihon Naika Gakkai Zasshi; 1997 Nov; 86(11):2046-51. PubMed ID: 9480308
    [No Abstract]   [Full Text] [Related]  

  • 3. The shiga-like toxin-producing Escherichia coli and hemolytic uremic syndrome.
    Cleary TG; Lopez EL
    Pediatr Infect Dis J; 1989 Oct; 8(10):720-4. PubMed ID: 2682505
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemolytic uremic syndrome associated with Escherichia coli O157:H7 infection in older adults: a case report and review of the literature.
    Ko H; Maymani H; Rojas-Hernandez C
    J Med Case Rep; 2016 Jun; 10():175. PubMed ID: 27301547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escherichia coli O157 in Somerset.
    Commun Dis Rep CDR Wkly; 1998 May; 8(19):167. PubMed ID: 9635338
    [No Abstract]   [Full Text] [Related]  

  • 6. [Enterohemorrhagic Escherichia coli and its infection: from 1977 to 1995].
    Takede Y
    Nihon Rinsho; 1997 Mar; 55(3):635-40. PubMed ID: 9086772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediators, markers, and modulators in the hemolytic uremic syndrome.
    Gruskin AB
    Am J Kidney Dis; 2000 Oct; 36(4):859-62. PubMed ID: 11007692
    [No Abstract]   [Full Text] [Related]  

  • 8. No common final pathogenetic pathway in haemolytic uraemic syndromes.
    Taylor CM; Howie AJ; Williams JM
    Nephrol Dial Transplant; 1999 May; 14(5):1100-2. PubMed ID: 10344345
    [No Abstract]   [Full Text] [Related]  

  • 9. Shiga toxin-producing Escherichia coli serotype OX3:H21 as a cause of hemolytic-uremic syndrome.
    Keskimäki M; Ikäheimo R; Kärkkäinen P; Scheutz F; Ratiner Y; Puohiniemi R; Siltonen A
    Clin Infect Dis; 1997 Jun; 24(6):1278-9; discussion 1280-2. PubMed ID: 9195109
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-partum haemolytic-uremic syndrome and verotoxin-producing Escherichia coli.
    Steele BT; Goldie J; Alexopoulou I; Shimizu A
    Lancet; 1984 Mar; 1(8375):511. PubMed ID: 6142233
    [No Abstract]   [Full Text] [Related]  

  • 11. Causes of the haemolytic uraemic syndrome.
    Kavi J; Wise R
    BMJ; 1989 Jan; 298(6666):65-6. PubMed ID: 2493295
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemolytic uremic syndrome: clinical picture and bacterial connection.
    Parsonnet J; Griffin PM
    Curr Clin Top Infect Dis; 1993; 13():172-87. PubMed ID: 8397909
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli.
    Jure MA; de Saab OA; de Castillo MC; Sesma F; Miceli S; Zamora AM; de Ruiz Holgado AP; de Nader OM
    Rev Latinoam Microbiol; 1998; 40(1-2):1-8. PubMed ID: 10932728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic-uremic syndrome in a six-year-old girl after a urinary tract infection with Shiga-toxin-producing Escherichia coli O103:H2.
    Tarr PI; Fouser LS; Stapleton AE; Wilson RA; Kim HH; Vary JC; Clausen CR
    N Engl J Med; 1996 Aug; 335(9):635-8. PubMed ID: 8687518
    [No Abstract]   [Full Text] [Related]  

  • 15. Impairment by verotoxin of tubular function contributes to the renal damage seen in haemolytic uraemic syndrome.
    Takeda T; Dohi S; Igarashi T; Yamanaka T; Yoshiya K; Kobayashi N
    J Infect; 1993 Nov; 27(3):339-41. PubMed ID: 8308331
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnetic resonance imaging of brain lesions of a patient with hemolytic uremic syndrome following Escherichia coli O157 infection.
    Yasuhara A; Araki A; Ochi A; Kobayashi Y
    Pediatr Int; 2000 Jun; 42(3):302-5. PubMed ID: 10881591
    [No Abstract]   [Full Text] [Related]  

  • 17. L-arginine as a therapeutic approach for the verotoxigenic Escherichia coli-induced hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.
    Jaradat ZW; Marquardt RR
    Med Hypotheses; 1997 Sep; 49(3):277-80. PubMed ID: 9293473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli.
    Mahon BE; Griffin PM; Mead PS; Tauxe RV
    Emerg Infect Dis; 1997; 3(3):409-12. PubMed ID: 9284395
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of adult hemolytic-uremic syndrome associated with Escherichia coli O157 infections].
    Nakagawa J; Toyooka S; Hayashi M; Kawase M; Mukaino S; Hirose Y; Tanaka T; Tanabe T; Nishikawa K; Sagou T
    Nihon Shokakibyo Gakkai Zasshi; 1998 Jan; 95(1):41-5. PubMed ID: 9483961
    [No Abstract]   [Full Text] [Related]  

  • 20. [Verotoxin induced hemolytic uremic syndrome: pathophysiology of neurological involvement].
    Takagi C; Naruse T
    Nihon Rinsho; 1997 Mar; 55(3):731-5. PubMed ID: 9086789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.